drugset / Trial / NCT02410655

An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery

NCT02410655

Phase 4 Withdrawn NYU Langone Health
Non-randomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study will be to evaluate a standardized, evidence-based protocol versus a conventional approach for the dosing of oxytocin in vaginal delivery.

Timeline

Start
2015-11
Primary completion
2017-07-27
Completion
2017-07-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 20 iu Intravenous
Comparator Oxytocin Peptide 30 iu Intravenous

Indications